# Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease

Study · id `cardio:ct-nct04511234` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04511234](<https://clinicaltrials.gov/study/NCT04511234>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04511234

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 279 participants.

## Technical summary

Registry record NCT04511234. Randomized; quadruple masking; primary purpose treatment. Start 2020-09-08 (actual); primary completion 2025-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 279 participants (planned count; ClinicalTrials.gov record NCT04511234, source copy `cardio:ctgov-nct04511234-2025-07-03`, retrieved 2026-10-31)
- Started: 2020-09-08 (actual) (ClinicalTrials.gov record NCT04511234, source copy `cardio:ctgov-nct04511234-2025-07-03`, retrieved 2026-10-31)
- Primary completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT04511234, source copy `cardio:ctgov-nct04511234-2025-07-03`, retrieved 2026-10-31)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT04511234, source copy `cardio:ctgov-nct04511234-2025-07-03`, retrieved 2026-10-31)
- Countries: Singapore; Taiwan; Thailand (ClinicalTrials.gov record NCT04511234, source copy `cardio:ctgov-nct04511234-2025-07-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04511234-2025-07-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
- Acronym: FUTURE-SFA
- Condition: Peripheral Artery Disease
- Condition: Atherosclerosis
- Condition: Arterial Disease
- Intervention (Device): MagicTouch PTA sirolimus drug coated balloon (DCB)
- Intervention (Device): POBA standard balloon
- Lead sponsor: Concept Medical Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Concept Medical Inc. (`cardio:org-concept-medical-inc`)

## Provenance

Content hash: 93e758d7a52d8b0995438e151956fc167191b1eaa8ea2a45bdde55f5969b7e94
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
